the adverse effects of acne/acne scar treated by photoelectric technology
Conditions
Interventions
acne of pure water group :The acne patients of pure water group were given 420nm intense pulsed light treatment after enrollment. Immediately after the treatment, they were sprayed with pure water a
acne of hydrogen water group:The acne patients of hydrogen water group were given 420nm intense pulsed light treatment after enrollment. Immediately after the treatment, they were sprayed with pure
acne scar of pure water group:The acne scar patients of pure water were given CO2 fractional laser treatment after enrollment. Immediately after the treatment, they were sprayed with pure water and
acne scar of hydrogen water group:The acne scar patients of hydrogen water group were given CO2 fractional laser treatment after enrollment. Immediately after the treatment, they were sprayed with n
Sponsors
the Affiliated Hospital of Chengde Medical University
Eligibility
Sex/Gender
All
Age
10 Years to 40 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria for the acne group: (1) No gender restrictions; age range 10-40 years old; (2) According to the diagnostic and grading standards of "Clinical Dermatology in China" and the modified Pillsbury classification method for acne, patients are diagnosed with Pillsbury II-IV grade acne (moderate to severe) with a history of more than 3 months; (3) Informed about the treatment content of this study, agreed to participate in the study and receive 420nm intense pulsed light treatment, and use pure water/nano bubble hydrogen water for repair after laser treatment; (4) Subjects are willing to refrain from using other skin care products, cosmetics and other facial treatments (such as: drugs, chemical peels, lasers, etc.) throughout the study period; (5) Comply with the trial requirements throughout the study period, complete the entire trial and be able to complete follow-up as required; (6) Have signed the informed consent form and are willing to complete the entire study process. Inclusion criteria for the acne scar group: (1) No gender restrictions; age range 16-40 years old; (2) Patients are diagnosed with atrophic acne scars, with a disease course of more than 3 months; (3) Informed about the treatment content of this study, agreed to participate in the study and receive CO2 fractional laser treatment, and use pure water/nano bubble hydrogen water for repair after laser treatment; (4) Subjects are willing to refrain from using other skin care products, cosmetics and other facial treatments (such as: drugs, chemical peels, lasers, etc.) throughout the study period; (5) Comply with the trial requirements throughout the study period, complete the entire trial and be able to complete follow-up as required; (6)Have signed the informed consent form and are willing to complete the entire study process.
Exclusion criteria
Exclusion criteria: Exclusion criteria for the acne group: (1) Pregnant, lactating, or in the preconception period; (2) Using systemic retinoid drugs within 3 months before enrollment or having used topical retinoid drugs within 1 month before enrollment; (3) Phototoxic individuals; (4) Using photosensitive drugs within 6 months before enrollment or having received phototoxic treatments within 1 month before enrollment; (5) Having received other facial phototherapies within 1 month before enrollment (such as drugs, radiofrequency laser, filling, dermabrasion, etc.); (6) Individuals with impaired heart, liver, or kidney function or with systemic diseases such as diabetes, nephropathy, hematological diseases, or mental disorders; (7) Individuals with malignant tumors. Exclusion criteria for the acne scar group: (1) Pregnant, lactating, or in the preconception period; (2) Having facial infections or showing signs of systemic infections; (3) Phototoxic or individuals with hypertrophic scar constitution; (4) Individuals with coagulation dysfunction; (5) Having received other facial treatments (such as drugs, radiofrequency laser, filling, dermabrasion, etc.) within 1 month before enrollment; (6) Individuals with impaired heart, liver, or kidney function or with systemic diseases such as diabetes, nephropathy, hematological diseases, or mental disorders; (7)Individuals with malignant tumors.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| pruritus,Numerical rating scale ;dryness,EEMCO Guidance;pain,Numerical rating scale;spots;brown spots;red area; | — |
Countries
China
Contacts
Public ContactLei he
the Affiliated Hospital of Chengde Medical University
Outcome results
None listed